These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2736117)

  • 1. Radical radiotherapy in prostatic carcinoma.
    Nilsson I; Lindholm CE; Landberg T; Abrahamsson PA; Sundkvist L; Lindholm K
    Acta Oncol; 1989; 28(2):261-6. PubMed ID: 2736117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prognostic factors in prostatic carcinoma treated with radical radiotherapy: stages A, B, and C].
    Rodríguez Villalba S; Magallón Sebastián R; Regueiro Otero C; Rodríguez Reina G; Romero Fernández J; Carballido Rodríguez J; De la Torre Tomás A; Aragón de la Cruz G
    Actas Urol Esp; 1996 Apr; 20(4):336-45. PubMed ID: 8801794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcome of radical radiation therapy for prostatic carcinoma: 1967-1987.
    Hahn P; Baral E; Cheang M; Math MC; Kostyra J; Roelss R
    Int J Radiat Oncol Biol Phys; 1996 Jan; 34(1):41-7. PubMed ID: 12118564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Primary radiotherapy of prostatic carcinoma--the results at Essen with 173 patients].
    Müller RD; Czeglarski G; Bamberg M; Budach V
    Strahlenther Onkol; 1987 Dec; 163(12):755-63. PubMed ID: 3424075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiation therapy for the management of localized prostate carcinoma.
    Burmeister BH; Probert JC
    Aust N Z J Surg; 1991 Sep; 61(9):658-62. PubMed ID: 1877932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate specific antigen-monitored combination radiotherapy for patients with prostate cancer. I-125 implant followed by external-beam radiation.
    Critz FA; Tarlton RS; Holladay DA
    Cancer; 1995 May; 75(9):2383-91. PubMed ID: 7536126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Survival after radical retropubic prostatectomy in patients with poorly differentiated prostatic carcinoma].
    Weigel C
    Strahlenther Onkol; 1996 Jul; 172(7):404-5. PubMed ID: 8693408
    [No Abstract]   [Full Text] [Related]  

  • 8. Prognostic significance of nodal involvement in locally advanced (stage C) carcinoma of prostate--RTOG experience.
    Pilepich MV; Johnson RJ; Perez CA; Krall JM; Russ HH; Zinninger M; Sause WT; Hanks GE; Martz KL
    Urology; 1987 Dec; 30(6):535-40. PubMed ID: 3318090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of prostate carcinoma death in patients with lymph node metastasis.
    Cheng L; Zincke H; Blute ML; Bergstralh EJ; Scherer B; Bostwick DG
    Cancer; 2001 Jan; 91(1):66-73. PubMed ID: 11148561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localized carcinoma of the prostate (stages T1B, T1C, T2, and T3). Review of management with external beam radiation therapy.
    Perez CA; Hanks GE; Leibel SA; Zietman AL; Fuks Z; Lee WR
    Cancer; 1993 Dec; 72(11):3156-73. PubMed ID: 7694785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term prostate cancer control using palladium-103 brachytherapy and external beam radiotherapy in patients with a high likelihood of extracapsular cancer extension.
    Dattoli M; Wallner K; True L; Cash J; Sorace R
    Urology; 2007 Feb; 69(2):334-7. PubMed ID: 17320673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Radiotherapy of localized prostatic carcinoma].
    Gez E; Netzer-Horowitz Y; Waiman E; Rubinov R; Cohen Y; Kuten A
    Harefuah; 1997 Dec; 133(12):593-6, 664. PubMed ID: 9451865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential benefit of improved local tumor control in patients with prostate carcinoma.
    Kuban DA; el-Mahdi AM; Schellhammer PF
    Cancer; 1995 May; 75(9):2373-82. PubMed ID: 7536125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for efficacy without increased toxicity of hypofractionated radiotherapy for prostate carcinoma: early results of a Phase III randomized trial.
    Yeoh EE; Fraser RJ; McGowan RE; Botten RJ; Di Matteo AC; Roos DE; Penniment MG; Borg MF
    Int J Radiat Oncol Biol Phys; 2003 Mar; 55(4):943-55. PubMed ID: 12605972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer control following anatomical radical prostatectomy: an interim report.
    Morton RA; Steiner MS; Walsh PC
    J Urol; 1991 Jun; 145(6):1197-200. PubMed ID: 1709704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.
    Le QT; Fu KK; Kaplan M; Terris DJ; Fee WE; Goffinet DR
    Cancer; 1999 Nov; 86(9):1700-11. PubMed ID: 10547542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3-D conformal radiotherapy for carcinoma of the prostate. Clinical experience at the Memorial Sloan-Kettering Cancer Center.
    Leibel SA; Kutcher GJ; Zelefsky MJ; Burman CM; Mohan R; Ling CC; Fuks Z
    Front Radiat Ther Oncol; 1996; 29():229-37. PubMed ID: 8742903
    [No Abstract]   [Full Text] [Related]  

  • 18. The effects of local and regional treatment on the metastatic outcome in prostatic carcinoma with pelvic lymph node involvement.
    Leibel SA; Fuks Z; Zelefsky MJ; Whitmore WF
    Int J Radiat Oncol Biol Phys; 1994 Jan; 28(1):7-16. PubMed ID: 8270461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors influencing outcome of definitive radiotherapy for localized carcinoma of the prostate.
    Perez CA; Garcia D; Simpson JR; Zivnuska F; Lockett MA
    Radiother Oncol; 1989 Sep; 16(1):1-21. PubMed ID: 2554371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonrandomized evaluation of pelvic lymph node irradiation in localized carcinoma of the prostate.
    Perez CA; Michalski J; Brown KC; Lockett MA
    Int J Radiat Oncol Biol Phys; 1996 Oct; 36(3):573-84. PubMed ID: 8948341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.